<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>2017</YEAR>
<VOL>15</VOL>
<NO>10</NO>
<MOSALSAL>0</MOSALSAL>
<PAGE_NO>668</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF>Reconstruction of mammalian oocytes by germinal vesicle transfer: A systematic review</TitleF>
		<TitleE>بازسازی تخمک های پستانداران با روش انتقال ژرمینال وزیکل: بررسی سیستماتیک</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>عملکرد میتوکندری و تعداد کپی DNA آن می&#173;تواند در بروز بسیاری از بیماری&#173;های انسانی نقش داشته باشد. اخیرا تکنیک انتقال هسته (NT) به عنوان تکنیک کمک باروری جدید در افزایش فعالیت میتوکندری سلول&#173;های تخمک در مقاصد تحقیقی و بالینی کاربرد زیادی دارد. در این مطالعه مروری با جمع&#173;آوری مقالات مستند از سال 1966 تا سبتامبر 2015، روش&#173;های مختلف انجام این تکنیک برای تخمک&#173;های نابالغ گزارش شده است. نتایج حاصل از این تحقیق نشان دهنده تمامی روش&#173;های انجام تکنیک انتقال وزیکول ژرمینال (GVT) در تخمک&#173;های پستانداران، بررسی میزان فیوژن و لقاح تخمک&#173;های حاصل و همچنین ارزیابی پتانسیل کاربرد کلینیکی این تکنیک می&#173;باشد. به نظر می&#173;رسد با مطالعه بر روی این تکنیک جدید می&#173;توان امیدوار بود در آینده نزدیک راهی برای درمان موثر تخمک&#173;های مسن یا تخمک&#173;های حاوی مشکلات میتوکندریایی گشوده گردد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Nuclear transfer procedures have been recently applied for clinical and research targets as a novel assisted reproductive technique and were used for increasing the oocyte activity during its growth and maturation. In this review, we summarized the nuclear transfer technique for germinal vesicle stage oocytes to reconstruct the maturation of them. Our study covered publications between 1966 and August 2017. In result utilized germinal vesicle transfer techniques, fusion, and fertilization survival rate on five different mammalian species are discussed, regarding their potential clinical application. It seems that with a study on this method, there is real hope for effective treatments of old oocytes or oocytes containing mitochondrial problems in the near future.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>601</FPAGE>
			<TPAGE>612</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/12/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/9/13
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/12/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/9/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>سارا</Name>
				<MidName></MidName>
				<Family>دربندی</Family>
				<NameE>Sara</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Darbandi</FamilyE>
				<Organizations>
				<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Akhondi@Avicenna.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مهسا</Name>
				<MidName></MidName>
				<Family>دربندی</Family>
				<NameE>Mahsa</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Darbandi</FamilyE>
				<Organizations>
				<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Akhondi@Avicenna.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>حمیدرضا</Name>
				<MidName></MidName>
				<Family>خرم خورشید</Family>
				<NameE>Hamid Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khorram Khorshid</FamilyE>
				<Organizations>
				<Organization>Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Akhondi@Avicenna.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>ابوالفضل</Name>
				<MidName></MidName>
				<Family>شیرازی</Family>
				<NameE>Abolfaz</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shirazi</FamilyE>
				<Organizations>
				<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Akhondi@Avicenna.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمدرضا</Name>
				<MidName></MidName>
				<Family>صادقی</Family>
				<NameE>Mohammad Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sadeghi</FamilyE>
				<Organizations>
				<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Akhondi@Avicenna.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>آشوک</Name>
				<MidName></MidName>
				<Family>آگاروال</Family>
				<NameE>Ashok</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Agarwal</FamilyE>
				<Organizations>
				<Organization>Center for Reproductive Medicine, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.</Organization>
				</Organizations>
				<Countries>
				<Country>امریکا</Country>
				</Countries>
				<EMAILS>
				<Email>Akhondi@Avicenna.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>صفا</Name>
				<MidName></MidName>
				<Family>الحسنی</Family>
				<NameE>Safaa</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Al-Hasani</FamilyE>
				<Organizations>
				<Organization>Reproductive Medicine Unit, University of Schleswig-Holstein, Luebeck, Germany</Organization>
				</Organizations>
				<Countries>
				<Country>آلمان</Country>
				</Countries>
				<EMAILS>
				<Email>Akhondi@Avicenna.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمدمهدی</Name>
				<MidName></MidName>
				<Family>نادری</Family>
				<NameE>Mohammad Mehdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Naderi</FamilyE>
				<Organizations>
				<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Akhondi@Avicenna.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>احمت</Name>
				<MidName></MidName>
				<Family>ایاز</Family>
				<NameE>Ahmet</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ayaz</FamilyE>
				<Organizations>
				<Organization>Yildiz Technical University, Istanbul, Turkey</Organization>
				</Organizations>
				<Countries>
				<Country>ترکیه</Country>
				</Countries>
				<EMAILS>
				<Email>Akhondi@Avicenna.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>محمدمهدی</Name>
				<MidName></MidName>
				<Family>آخوندی</Family>
				<NameE>Mohammad Mehdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Akhondi</FamilyE>
				<Organizations>
				<Organization>Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Akhondi@Avicenna.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Germinal vesicle</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Micromanipulation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Nuclear transfer</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Oocyte</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>انتقال وزیکل ژرمینال</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>انتقال هسته</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تخمک نابالغ.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Sun QY, Lai L, Bonk A, Prather RS, Schatten H. Cytoplasmic changes in relation to nuclear maturation and early embryo developmental potential of porcine oocytes: effects of gonadotropins, cumulus cells, follicular size, and protein synthesis inhibition. Mol Reprod Dev 2001; 59: 192-198.##Gao S, Gasparrini B, McGarry M, Ferrier T, Fletcher J, Harkness L, et al. Germinal vesicle material is essential for nucleus remodeling after nuclear transfer. Biol Reprod 2002; 67: 928-934.##Darbandi S, Darbandi M, Sadeghi MR, Al-Hasani S, Agarwal A, Shirazi A, et al. Experimental strategies towards increasing intracellular mitochondrial activity in oocytes: A systematic review. Mitochondrion 2016; 30: 8-17.##Neupane J, Vandewoestyne M, Ghimire S, Lu Y, Qian C, Van Coster R, et al. Assessment of nuclear transfer techniques to prevent the transmission of heritable mitochondrial disorders without compromising embryonic development competence in mice. Mitochondrion 2014; 18: 27-33.##Brown DT, Herbert M, Lamb VK, Chinnery PF, Taylor RW, Lightowlers RN, et al. Transmission of mitochondrial DNA disorders: possibilities for the future. Lancet 2006; 368: 87-89.##Fulka H. Distribution of mitochondria in reconstructed mouse oocytes. Reproduction 2004; 127: 195-200.##Han Z, Cheng Y, Liang CG, Latham KE. Nuclear transfer in mouse oocytes and embryos. Methods Enzymol 2010; 476: 171-184.##Yoshida N, Perry AC. Piezo-actuated mouse intracytoplasmic sperm injection (ICSI). Nat Protoc 2007; 2: 296-304.##Mohammed AA, Karasiewicz J, Modlinski JA. Developmental potential of selectively enucleated immature mouse oocytes upon nuclear transfer. Mol Reprod Dev 2008; 75: 1269-1280.##Takeuchi T, Ergün B, Huang TH, Rosenwaks Z, Palermo GD. A reliable technique of nuclear transplantation for immature mammalian oocytes. Hum Reprod 1999; 14: 1312-1317.##Cheng Y, Wang K, Kellam LD, Lee YS, Liang CG, Han Z, et al. Effects of ooplasm manipulation on DNA methylation and growth of progeny in mice. Biol Reprod 2009; 80: 464-472.##Takeuchi T, Rosenwaks Z, Palermo GD. A successful model to assess embryo development after transplantation of prophase nuclei. Hum Reprod 2004; 19: 975-981.##Komarova Y, Peloquin J, Borisy G. Components of a Microinjection System. Cold Spring Harb Protoc 2011; 2011: 935-939.##Takeuchi T, Neri QV, Katagiri Y, Rosenwaks Z, Palermo GD. Effect of treating induced mitochondrial damage on embryonic development and epigenesis. Biol Reprod 2005; 72: 584-592.##Franciosi F, Perazzoli F, Lodde V, Modina SC, Luciano AM. Developmental competence of gametes reconstructed by germinal vesicle transplantation from fresh and cryopreserved bovine oocytes. Fertil Steril 2010; 93: 229-238.##Luciano AM, Franciosi F, Lodde V, Perazzoli F, Slezakova M, Modina S. Cryopreservation of immature bovine oocytes to reconstruct artificial gametes by germinal vesicle transplantation. Reprod Domest Anim 2009; 44: 480-488.##Wang C-W, Lai Y-M, Chan P-R, Horng S-G, Chang C-L, Chen C-K, et al. Resumption of meiosis-I after transfer of mouse primordial oocytes from frozen-thawed ovarian tissue to enucleated preovulatory oocytes: A preliminary report. J Assist Reprod Genet 2002; 19: 493-499.##Liu H, Wang CW, Grifo JA, Krey LC, Zhang J. Reconstruction of mouse oocytes by germinal vesicle transfer: maturity of host oocyte cytoplasm determines meiosis. Hum Reprod 1999; 14: 2357-2361.##Liu H, Zhang J, Krey LC, Grifo JA. In-vitro development of mouse zygotes following reconstruction by sequential transfer of germinal vesicles and haploid pronuclei. Hum Reprod 2000; 15: 1997-2002.##Kobayashi M , Sato K. Mitochondrial behavior and localization in reconstituted oocytes derived from germinal vesicle transfer. Hum Cell 2008; 21: 7-11.##Moffa F, Comoglio F, Krey LC, Grifo JA, Revelli A, Massobrio M, et al. Germinal vesicle transfer between fresh and cryopreserved immature mouse oocytes. Hum Reprod 2002; 17: 178-183.##Li G, Lian L, Wang MK, Lian Y, Chen DY. Maturation of the reconstructed oocytes by germinal vesicle transfer in rabbits and mice. Theriogenology 2001; 56: 855-866.##Li GP, Chen DY, Lian L, Sun QY, Wang MK, Song XF, et al. Mouse‐rabbit germinal vesicle transfer reveals that factors regulating oocyte meiotic progression are not species‐specific in mammals. J Exp Zool 2001; 289: 322-329.##https://doi.org/10.1002/1097-010X(20010415/30)289:5&lt;322::AID-JEZ6&gt;3.0.CO;2-B##Consiglio AL, Bignotti A, Pecile AM, Cremonesi F. Reconstruction of calf oocytes by germinal vesicle transfer in mature bovine oocytes: preliminary results. Vet Res Commun 2009; (Suppl.): 89-92.##Bao S, Ushijima H, Hirose A, Aono F, Ono Y, Kono T. Development of bovine oocytes reconstructed with a nucleus from growing stage oocytes after fertilization in vitro. Theriogenology 2003; 59: 1231-1239.##Zhang J, Wang CW, Krey L, Liu H, Meng L, Blaszczyk A, et al. In vitro maturation of human preovulatory oocytes reconstructed by germinal vesicle transfer. Fertil Steril 1999; 71:. 726-731.##Palermo GD, Takeuchi T, Rosenwaks Z. Oocyte-induced haploidization. Reprod Biomed Online 2002; 4: 237-242.##Zhang J. Revisiting Germinal Vesicle Transfer as a Treatment for Aneuploidy in Infertile Women with Diminished Ovarian Reserve. J Assist Reprod Genet 2015; 32: 313-317.##Szczygiel MA, Kusakabe H, Yanagimachi R, Whittingham DG. Intracytoplasmic sperm injection is more efficient than in vitro fertilization for generating mouse embryos from cryopreserved spermatozoa. Biol Reprod 2002; 67: 1278-1284.##Nagai S, Kasai T, Hirata S, Hoshi K, Yanagimachi R, Huang T. Cytoplasmic transfer in the mouse in conjunction with intracytoplasmic sperm injection. Reprod BioMed Online 2004; 8: 75-80.##Kimura Y, Yanagimachi R. Intracytoplasmic sperm injection in the mouse. Biol Reprod 1995; 52: 709-720.##Cui LB, Huang XY, Sun FZ. Transfer of germinal vesicle to ooplasm of young mice could not rescue ageing-associated chromosome misalignment in meiosis of oocytes from aged mice. Hum Reprod 2005; 20: 1624-1631.##Zhang J, Liu H. Cytoplasm replacement following germinal vesicle transfer restores meiotic maturation and spindle assembly in meiotically arrested oocytes. Reprod Biomed Online 2015; 31: 71-78.##Modlusński JA. Haploid mouse embryos obtained by microsurgical removal of one pronucleus. J Embryol Exp Morphol 1975; 33: 897-905.##Gręda P, Karasiewicz J, Modliński JA. Mouse zygotes as recipients in embryo cloning. Reproduction 2006; 132: 741-748.##Cheng Y, Fan HY, Wen DC, Tong C, Zhu ZY, Lei L, et al. Asynchronous cytoplast and karyoplast transplantation reveals that the cytoplasm determines the developmental fate of the nucleus in mouse oocytes. Mol Reprod Dev 2003; 65: 278-282.##Wang ZW, Zhang GL, Schatten H, Carroll J, Sun QY. Cytoplasmic Determination of Meiotic Spindle Size Revealed by a Unique Inter-Species Germinal Vesicle Transfer Model. Sci Rep 2016; 6: 19827.##Kárníková L, Urban F, Moor R, Fulka J Jr. Mouse oocyte maturation: the effect of modified nucleocytoplasmic ratio. Reprod Nutr Dev 1998; 38: 665-670.##Han Z, Chung YG, Gao S, Latham KE. Maternal factors controlling blastomere fragmentation in early mouse embryos. Biol Reprod 2005; 72: 612-618.##Grabarek JB, Plusa B, Modlinski JA, Karasiewicz J. Reconstruction of enucleated mouse germinal vesicle oocytes with blastomere nuclei. Zygote 2004; 12: 163-172.##Tsunoda Y, Tokunaga T, Imai H, Uchida T. Nuclear transplantation of male primordial germ cells in the mouse. Development 1989; 107: 407-411.##Piotrowska-Nitsche K, Chan AW. Effect of sperm entry on blastocyst development after in vitro fertilization and intracytoplasmic sperm injection-mouse model. J Assist Reprod Genet 2013; 30: 81-89.##Pavlok A, Lapathitis G, Cech S, Kubelka M, Lopatarova M, Holy L, et al. Simulation of intrafollicular conditions prevents GVBD in bovine oocytes: a better alternative to affect their developmental capacity after two-step culture. Mol Reprod Dev 2005; 71: 197-208.##Rose‐Hellekant TA, Bavister BD. Roles of protein kinase A and C in spontaneous maturation and in forskolin or 3‐isobutyl‐1‐methylxanthine maintained meiotic arrest of bovine oocytes. Mol Reprod Dev 1996; 44: 241-249.##https://doi.org/10.1002/(SICI)1098-2795(199606)44:2&lt;241::AID-MRD14&gt;3.0.CO;2-5##Kono T, Sotomaru Y, Aono F, Takahasi T, Ogiwara I, Sekizawa F, et al. Effect of ooplast activation on the development of oocytes following nucleus transfer in cattle. Theriogenology 1994; 41: 1463-1471.##Kono T, Obata Y, Yoshimzu T, Nakahara T, Carroll J. Epigenetic modifications during oocyte growth correlates with extended parthenogenetic development in the mouse. Nat Genet 1996; 13: 91-94.##Bao S, Obata Y, Carroll J, Domeki I, Kono T. Epigenetic modifications necessary for normal development are established during oocyte growth in mice. Biol Reprod 2000; 62: 616-621.##McGrath J, Solter D. Nuclear transplantation in the mouse embryo by microsurgery and cell fusion. Science 1983; 220: 1300-1302.##Kwon OY, Kono T. Production of identical sextuplet mice by transferring metaphase nuclei from four-cell embryos. Proc Nati Acad Sci 1996; 93: 13010-13013.##Dang-Nguyen TQ, Appeltant R, Somfai T, Ishihara S, Men NT, Santos EC, et al. Improvement of the developmental competence of porcine oocytes collected from early antral follicles by cytoplast fusion. J Reprod Dev 2017; 63: 59-65.##Tesarik J, Mendoza C, Greco E. Paternal effects acting during the first cell cycle of human preimplantation development after ICSI. Hum Reprod 2002; 17: 184-189.##Tesarik J, Martinez F, Rienzi L, Ubaldi F, Iacobelli M, Mendoza C, et al. Microfilament disruption is required for enucleation and nuclear transfer in germinal vesicle but not metaphase II human oocytes. Fertil Steril 2003; 79 (Suppl.): 677-681.##Palermo GD, Cohen J, Rosenwaks Z. Intracytoplasmic sperm injection: a powerful tool to overcome fertilization failure. Fertil Steril 1996; 65: 899-908.##Tesarik J, Sousa M, Testart J. Human oocyte activation after intracytoplasmic sperm injection. Hum Reprod 1994; 9: 511-518.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The prevalence of, and risk factors for, mycoplasma genitalium infection among infertile women in Ibadan: A cross-sectional study</TitleF>
		<TitleE>شیوع و عوامل خطر عفونت میکوپلاسما ژنیتالیس در بین زنان نابارور در ایبادان:یک مطالعه مقطعی

</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: ارتباط میکوپلاسما ژنیتالیس با ناباروری ثابت شده است. این عفونت&#173;ها بدون علامت و از نظر تشخیصی مشکل می&#173;باشد. فهم عوامل خطر مرتبط میتواند تسهیل بخش غربالگری بهتر گروه&#173;های در معرض خطر باشد.
هدف: هدف از انجام این مطالعه، تشخیص شیوع و عوامل خطر عفونت میکروباکتریوم ژنیتالیس در بین زنان نابارور در ایبادان بود. 
موارد و روش&#173;ها: این مطالعه به صورت مقطعی در 2 بیمارستان در ایبادان بر روی 267 زن نابارور و 135 زن بارور بین مارچ تا نوامبر 2015 انجام شد. با استفاده از یک پرسشنامه طراحی شده، اطلاعات اقتصادی و خصوصیات رفتاری مراجعین جمع&#173;آوری و سپس نمونه سواپ اندوسرویکس جهت بررسی میکروباکتریوم ژنیتالیس تهیه شد. ژن MgPa به وسیله PCR بررسی شد. باندهای باند شده 495 کیلو باز بعنوان نمونه مثبت میکروباکتریوم ژنیتالیس در نظر گرفته شد.
نتایج: در بین زنان نابارور 43 نفر (10/16%) شواهد عفونت میکروباکتریوم ژنیتالیس را داشتند. در صورتی که تنها 3 نفر (2/2%) از زنان بارور مبتلا بودند (001/0&#62;p). عوامل خطر همراه شامل: وجود بیش از یک شریک جنسی در زندگی (97/33-76/3CI: &#160;95% ،13/10OR:)، وجود شریک جنسی دیگر برای شوهر (63/90-08/2CI: &#160;95% ،88/12OR:)، منوگالیستی متوالی (ازدواج&#173;های متعدد بعد از مرگ همسر) (27/8-35/4CI: &#160;95% ،6OR:) و شرایط اقتصادی- اجتماعی پایین (10/6-28/1CI: &#160;95% ،80/2OR:). هیچ ارتباطی بین سابقه&#173;های قبلی عفونت&#173;های انتقال یافته از طریق جنسی و میکروباکتریوم ژنیتالیس پیدا نشد.
نتیجه &#173;گیری: ریسک عفونت میکروباکتریوم ژنیتالیس مشابه دیگر بیماری&#173;های انتقال یافته از نظر جنسی می&#173;باشد. لذا غربالگری معمولی باید به روش&#173;های جدیدتر جهت بررسی میکروبی زنان نابارور تغییر یابد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: The association of mycoplasma genitalium (M. genitalium) with infertility has been documented. The infections are asymptomatic and difficult to diagnose. Understanding the associated risk factors will help in facilitating better screening measures for at-risk groups.
Objective: The aim was to determine the prevalence of, and risk factors for, M. genitalium infection among infertile women in Ibadan.
Materials and Methods: In this cross-sectional study, 402 women (267 infertile and 135 fertile) referred to 2 hospitals in Ibadan between March and November 2015 were enrolled. Information was obtained, using structured questionnaire, on sociodemographic and behavioral characteristics of the respondents while endocervical swabs were obtained for detection of M. genitalium. MgPa gene was diagnosed using the conventional Polymerase chain reaction. Bands corresponding to 495kb were documented as positive for M. genitalium.
Results: Among the infertile women, 43 (16.1%) had evidence of M. genitalium infection as against 3 (2.2%) of women without infertility (p&#60;0.001). Associated risk factors included having more than one lifetime sexual partner (OR=10.13, 95% CI: 3.76-33.97); husbands having other sexual partners (OR=12.88, 95% CI: 2.08-90.63); being a serial monogamist (OR=6, 95% CI: 4.35-8.27) and low socio-economic status (OR=2.80, 95% CI: 1.28-6.10). No relationship exists between the previous history of sexually transmitted infections and M. genitalium.
Conclusion: The risk factors for M. genitalium infection are similar to those peculiar to other sexually transmitted infections. Its routine screening should be incorporated into the current protocol for microbiological evaluation of infertile women.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>613</FPAGE>
			<TPAGE>618</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/12/42017/12/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/9/13
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/12/42017/12/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/9/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Tinuade Adesola</Name>
				<MidName></MidName>
				<Family>Ajani</Family>
				<NameE>Tinuade Adesola</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ajani</FamilyE>
				<Organizations>
				<Organization>Department of Medical Microbiology, University College Hospital, Ibadan, Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>sesanoluwasola@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Timothy A. Olusesan</Name>
				<MidName></MidName>
				<Family>Oluwasola</Family>
				<NameE>Timothy A. Olusesan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Oluwasola</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynaecology, University College Hospital, Ibadan and College of Medicine, University of Ibadan, Ibadan. Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>sesanoluwasola@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mustapha</Name>
				<MidName></MidName>
				<Family>A. Ajani</Family>
				<NameE>Mustapha</NameE>
				<MidNameE></MidNameE>
				<FamilyE>A. Ajani</FamilyE>
				<Organizations>
				<Organization>Department of Histopathology, Babcock University, Ilishan-Remo, Ogun State, Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>sesanoluwasola@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Rasheed</Name>
				<MidName></MidName>
				<Family>Ajani Bakare</Family>
				<NameE>Rasheed</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ajani Bakare</FamilyE>
				<Organizations>
				<Organization>Department of Medical Microbiology, College of Medicine, University of Ibadan, Ibadan, Nigeria</Organization>
				</Organizations>
				<Countries>
				<Country>Nigeria</Country>
				</Countries>
				<EMAILS>
				<Email>sesanoluwasola@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Infertility</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Mycoplasma genitalium</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Prevalence</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Risk factors</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Screening</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ناباروری</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>میکوپلاسما ژنیتالیس</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>شیوع</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>عوامل خطر</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>غربالگری.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Zegers-Houchschild F, Adamson GD, de Mouson J, Ishiara O, Masour R, Nygren K et al. International committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril 2009; 92: 1520-1524.##Durgesh DG, Bajaj JK, Damle SA, Jayanti MP, Sonali D, Shilpa CK. Study of Chlamydia trachomatis in infertile women. Ind J Res 2013; 2: 260-263.##McGowin CL, Anderson-Smits C. Mycoplasma genitalium: An emerging cause of sexually transmitted disease in women. PLoS Pathog 2011; 7: e1001324.##Grześko J, Elias M, Maczyńska B, Kasprzykowska U, Tłaczała M, Goluda M. Occurrence of mycoplasma genitalium in fertile and infertile women. Fertil Steril 2009; 91: 2376-2380.##Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium Infection and female reproductive tract disease: A meta-analysis. Clin Infect Dis 2015; 61: 418-426.##Manhart LE, Holmes KK, Hughes JP, Houston LS, Totten PA. Mycoplasma genitalium among young adults in the United States: An emerging sexually transmitted infection. Am J Public Health 2007; 97: 1118-1125.##Plečko V, Zele Starčević L, Tripković V, Rezo Vranješ V, Skerlev M. Mycoplasma genitalium: Clinical Significance and Diagnosis. Acta Dermatovenerol Croat 2013; 21: 236-240.##Razin S. Mycoplasma. In Topley &amp; Wilson's Microbiology and Microbial Infections. Wiley-Blackwell. Available at: http://dx.doi.org/10.1002/ 9780470688618.taw0077.##Jombo G, Enenebeaku M, Peters E, Itam H, Mbaawuaga E. Symptomatic genital Mycoplasmal infections among ante-natal women in an urban community of northern Nigeria and the need to possibly widen the scope of present laboratory investigations. Int J Infect Dis 2008; 7: 1-7##Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunharm RC, Holmes KK, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765-766.##Simms I, Eastick K, Mallinson H, Thomas K, Gokhale R, Hay P, et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease. J Clin Pathol 2003; 56: 616-618.##Haggerty CL, Totten PA, Astete SG, Ness RB. Mycoplasma Genitalium among women With Nongonococcal, Nonchlamydial Pelvic Inflammatory Disease. Infect Dis Obstet Gynecol 2006; 2006: 30184.##Daley GM, Russell DB, Tabrizi SN, McBride J. Mycoplasma genitalium: a review. Int J STD AIDS 2014; 25: 475-487.##Ibadin KO, Osemwenkha AP, Ibeh IN. Urogenital tract infection in asymptomatic male patients with infertility in University of Benin teaching hospital, Benin City, Edo State. Malaysian J Microbiol 2012; 8: 289-292.##Anaedobe CG, Fowotade A, Omoruyi CE, Bakare RA. Prevalence, socio-demographic features and risk factors of Hepatitis B virus infection among pregnant women in Southwestern Nigeria. Pan Afr Med J 2015; 20: 406.##Chukwuka CP, Agbakoba NR, Emele FE, Oguejiofor C, Akujobi CN, Ezeagwuna DA, et al. Prevalence of genital Mycoplasmas in the vaginal tracts of adolescents in Nnewi, south-eastern, Nigeria. World J Med Sci 2013; 9: 248-253.##Mohseni Moghadam N, Kheirkhah B, Mirshekari TR, Fasihi Harandi M, Tafsiri E. Isolation and molecular identification of mycoplasma genitalium from the secretion of genital tract in infertile male and female. Iran J Reprod Med 2014; 12: 601-608.##Clausen HF, Fedder J, Drasbek M, Nielsen PK, Toft B, Ingerslev HJ et al. Serological investigation of Mycoplasma genitalium in infertile women. Hum Reprod 2001; 16: 1866-1874.##Tomusiak A, Heczko PB, Janeczko J, Adamski P, Pilarczyk-Żurek M, Strus M. Bacterial infections of the lower genital tract in fertile and infertile women from the southeastern Poland. Ginekol Pol 2013; 84: 352-358.##Rajkumar N, Sethi S, Dhaliwal L, Gupta N, Yadav R, Banga S, et al. Role of Mycoplasma genitalium in infertility and bad obstetric history in Indian non-pregnant women: a pilot study. Int J Infect Dis 2012; 16: e270.##Edberg A, Jurstrand M, Johansson E, Wikander E, Hoog A, Ahigvist T, et al. A comparative study of three different PCR assays for detection of Mycoplasma genitalium in urogenital specimens from men and women. J Med Microbiol 2008; 57: 304-309.##Müller EE, Venter JM, Magooa MP, Morrison C, Lewis DA, Mavedzenge SN. Development of a rotor-gene real-time PCR assay for the detection and quantification of mycoplasma genitalium. J Microbiol Methods 2012; 88: 311-315.##Svenstrup HF, Jensen JS, Björnelius E, Lidbrink P, Birkelund S, Christiansen G. Development of a quantitative real-time PCR assay for detection of mycoplasma genitalium. J Clin Microbiol 2005; 43: 3121-3128.##Andersen B, Sokolowski I, Østergaard L, Kjølseth Møller J, Olesen F, Jensen JS. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Trans Infect 2007; 83: 237-241.##Oakeshott P, Aghaizu A, Hay P, Reid F, Kerry S, Atherton H et al. Is mycoplasma genitalium in women the &quot;New Chlamydia?&quot; A community-based prospective cohort study. Clin infect Dis 2010; 51: 1160-1166.##Svenstrup HF, Dave SS, Carder C, Grant P, Morris-Jones S, Kidd M, et al. A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London. BMJ Open 2014; 4: e003947.##Thurman AR, Musatovova O, Perdue S, Shain RN, Baseman JG, Baseman JB. Mycoplasma genitalium symptoms, concordance and treatment in high risk sexual dyads. Int J STD AIDS 2010; 21: 177-183.##Tosh AK, Van Der Pol B, Fortenberry JD, Williams JA, Katz BP, Batteiger BE, et al. Mycoplasma genitalium among adolescent women and their partners. J Adolesc Health 2007; 40: 412-417.##Xiang Z, Yin YP, Shi MQ, Jiang N, Han Y, Wang HC, et al. Risk factors for Mycoplasma genitalium infection among female sex workers: a cross-sectional study in two cities in southwest China. BMC Public Health 2012; 12: 414.##Hancock EB, Manhart LE, Nelson SJ, Kerani R, Wroblewski JKH, Totten PA. Comprehensive assessment of sociodemographic and behavioral risk factors for mycoplasma genitalium infection in women. Sex Transm Dis 2010; 37: 777-783.##Vandepitte J, Muller E, Bukenya J, Nakubulwa S, Kyakuwa N, Buvé A, et al. Prevalence and correlates of Mycoplasma genitalium infection among female sex workers in Kampala, Uganda. J Infect Dis 2012; 205: 289-296.##Pépin J, Labbe AC, Khonde N, Deslandes S, Alary M, Dzokoto A, et al. Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers. Sex Transm Infect 2005; 81: 67-72.##Eftekhar M, Pourmasuni S, Sabeti P, Aflatoonian A, Sheikhha H. Mycobacterium tuberculosis infection in women with unexplained infertility. Int J Reprod BioMed 2015; 13: 749-754## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>CXC Ligand 5 cytokine serum level in women with polycystic ovary syndrome and normal body mass index: A case-control study</TitleF>
		<TitleE>سطح سرمی CXCL5 در زنان با سندرم تخمدان پلی کیستیک و BMI نرمال: یک مطالعه مورد-شاهدی

</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: سندرم تخمدان پلی&#173;کیستیک (PCOS) متداول&#173;ترین بیماری اندوکرین می&#173;باشد و مرتبط با مقاومت به انسولین می&#173;باشد. CXCL5 سیتوکین جدیدی است که از بافت چربی سفید در شرایط چاقی ترشح می&#173;گردد و با مهار کردن مسیر سیگنالینگ انسولین باعث مهار فعالیت انسولین و پیشبرد مقاومت به انسولین می&#173;گردد.
هدف: هدف این مطالعه ارزیابی سطح سرمی CXCL5 در زنان PCOS با BMI نرمال می&#173;باشد.
موارد و روش&#173;ها: این مطالعه یک مطالعه مورد- شاهدی است که 30 زن مبتلا به سندرم تخمدان پلی&#173;کیستیک (PCOS) با BMI نرمال به عنوان گروه بیمار و 30 زن سالم (عدم PCOS) با BMI نرمال به عنوان گروه کنترل انتخاب شدند. سطح سرمی انسولین و سیتوکین CXCL5 و دیگر فاکتور&#173;های هورمونی مرتبط به روش الیزا و پارامتر&#173;های بیوشیمیایی به کمک اتوآنالیزر اندازه&#173;گیری شدند.
نتایج: نتایج این مطالعه افزایش معناداری را در غلظت انسولین، HOMA-IR، LH، LH/FSH، FBS، تستوسترون و پرولاکتین در گروه PCOS در مقایسه با گروه کنترل نشان داد در حالی که غلظت&#173;های CXCL5 ،کلسترول،LDL-C ، HDL-C، DHEAS، کراتینین و HOMA-B در بین دو گروه تفاوتی نداشت.
نتیجه&#173; گیری: در این مطالعه تفاوت معناداری در غلظت سرمی CXCL5 در خانم&#173;های PCOS با BMI نرمال مشاهده نشد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disease and associated with insulin resistance. CXC Ligand 5 (CXCL5) is a new cytokine which is secreted from white adipose tissue during obesity and by blocking insulin signaling pathway inhibits the activity of insulin and promotes insulin resistance.
Objective: The aim of this study was to assess serum level of CXCL5 in PCOS women with normal body mass index.
Materials and Methods: In this case-control study, 30 PCOS women with normal body mass index as the case group and 30 non-PCOS women as the controls were enrolled. Serum levels of CXCL5, insulin and other hormones factors related with PCOS were measured by ELISA method, also the biochemical parameters were measured by autoanalyzer.
Results: Significant increases in serum insulin concentration, homeostasis model assessments of insulin resistance, luteinizing hormone, luteinizing hormone/follicle-stimulating hormone, fasting blood sugar, testosterone, and prolactin were observed in the case group compared to the controls. were in the serum level of CXCL5, cholesterol, low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol,dehydroepiandrosterone-sulfate, creatinine, and homeostasis model assessment of beta cell function between these two groups.
Conclusion: In this study, no significant change was observed in serum concentrations of CXCL5 in PCOS women with normal BMI.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>619</FPAGE>
			<TPAGE>624</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/12/42017/12/42017/12/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/9/13
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/12/42017/12/42017/12/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/9/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>مرضیه</Name>
				<MidName></MidName>
				<Family>ظهرابی</Family>
				<NameE>Marzieh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Zohrabi</FamilyE>
				<Organizations>
				<Organization>The Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Smdakbarzadeh@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>الهام</Name>
				<MidName></MidName>
				<Family>رحمانی</Family>
				<NameE>Elham</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rahmani</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Faculty of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Smdakbarzadeh@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>نیلوفر</Name>
				<MidName></MidName>
				<Family>معتمد</Family>
				<NameE>Niloofar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Motamed</FamilyE>
				<Organizations>
				<Organization>Department of Community Medicine, Faculty of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Smdakbarzadeh@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>صمد</Name>
				<MidName></MidName>
				<Family>اکبرزاده</Family>
				<NameE>Samad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Akbarzadeh</FamilyE>
				<Organizations>
				<Organization>Department of Biochemistry, Faculty of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Smdakbarzadeh@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Polycystic ovary syndrome</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Insulin resistance</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>CXCL5 cytokine</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hyperinsulinemia</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hyperandrogenism</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سندرم تخمدان پلی‌کیستیک</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مقاومت به انسولین</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سیتوکین CXCL5</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هیپرانسولینمیا</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هیپراندروژنیسم.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Eftekhar T, Sohrabvand F, Zabandan N, Shariat M, Haghollahi F, Ghahghaei-Nezamabadi A. Sexual dysfunction in patients with polycystic ovary syndrome and its affected domains. Iran J Reprod Med 2014; 12: 539-546.##Nadjarzadeh A, Dehghani Firouzabadi R, Vaziri N, Daneshbodi H, Lotfi MH, Mozaffari-Khosravi H. The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial. Iran J Reprod Med 2013; 11: 665-672.##Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 2013; 6: 1-13.##The Rotterdam ESHRE/ASRM‐sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004; 19: 41-47.##Akbarzadeh S, Ghasemi S, Kalantarhormozi M, Nabipour I, Abbasi F, Aminfar A, et al. Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI. Gynecol Endocrinol 2012; 28: 521-524.##Wild RA, Painter PC, Coulson PB, Carruth KB, Ranney GB. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985; 61: 946-951.##Wang HS, Wang TH. Polycystic Ovary Syndrome (PCOS), Insulin Resistance and Insulin-Like Growth Factors (IGFs)/IGF-Binding Proteins (IGFBPs). Chang Gung Med J 2003; 26: 540-553.##Dunaif A, Xia J, Book CB, Schenker E, Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 1995; 96: 801-810.##Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenismdue to dysregulation of androgen secretion. Endocr Rev 1995; 16: 322-353.##Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774-800.##Bremer AA, Miller WL. The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance. Fertil Steril 2008; 89: 1039-1048.##Chavey C, Lazennec G, Lagarrigue S, Clapé C, Iankova I, Teyssier J, et al. CXCL5 is an adipose tissue derived factor that links obesity to insulin resistance. Cell Metab 2009; 9: 339-349.##Tacke F, Zimmermann HW, Trautwein C, Schnabl B. CXCL5 plasma levels are decreased in patients with chronic liver Disease. J Gastroenterol Hepatol 2011; 26: 523-529.##Chavey C, Fajas L. CXCL5 drives obesity to diabetes and further. Aging (Albany NY) 2009; 1: 674-677.##Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387: 917-921.##Yao L, Herlea-Pana O, Heuser-Baker J, Chen Y, Barlic-Dicen J. Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease. J Immunol Res 2014; 2014: 181450.##Friedwald WT, Levy RT, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.##Chutia H, Lynrah KG. Association of serum magnesium deficiency with insulin resistance in type 2 diabetes mellitus. J Lab Physicians 2015; 7: 75-78.##Nasrat H, Patra SK, Goswami B, Jain A, Raghunandan C. Study of association of leptin and insulin resistance markers in patients of PCOS. Indian J Clin Biochem 2016; 31: 104-107.##Kyaw Tun T, McGowan A, Phelan N, Correia N, Boran G, O'Connor AL, et al. Obesity and insulin resistance are the main determinants of postprandial lipoprotein dysmetabolism in polycystic ovary syndrome. Int J Endocrinol 2016; 2016: 9545239.##Layegh P, Mousavi Z, Farrokh Tehrani D, Parizadeh SM, Khajedaluee M. Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients. Int J Reprod Biomed 2016; 14: 263-270.##Chen MJ, Chou CH, Chen SU, Yang WS, Yang YS, Ho HN. The effect of androgens on ovarian follicle maturation: Dihydrotestosterone suppress FSH-stimulated granulosacell proliferation by upregulating PPARγ-dependent PTEN Expression. Sci Rep 2015; 5: 18319.##Sharquie KE, Al-Bayatti AA, Al-Ajeel AI, Al-Bahar AJ, Al-Nuaimy AA. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome. Saudi Med J 2007; 28: 1039-1043.##Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006; 91: 4237-4245.##Laganà AS, Rossetti P, Buscema M, La Vignera S, Condorelli RA, Gullo G, et al. Metabolism and ovarian function in PCOS women: A therapeutic approach with inositols. Int J Endocrinol 2016; 2016: 6306410.##Kumar AN, Naidu JN, Satyanarayana U, Ramalingam K, Anitha M. Metabolic and endocrine characteristics of Indian women with polycystic ovary syndrome. Int J Fertil Steril 2016; 10: 22-28.##Nizam K, Memon N, Devrajani BR. Outcome of treatment with lisuride in hyperprolactinemic infertile women. J Liaquat Uni Med Health Sci 2008; 7: 120-123.##Eftekhar M, Khalili MA, Rahmani E. The efficacy of recombinant versus urinary HCG in ART outcome. Iran J Reprod Med 2012; 10: 543-548.##Aflatoonian A, Rahmani E, Rahsepar M. Assessing the efficacy of aspiration and ethanol injection in recurrent endometrioma before IVF cycle: A randomized clinical trial. Iran J Reprod Med 2013; 11: 179-184.##Eftekhar M, Dehghani Firouzabadi R, Karimi H, Rahmani E. Outcome of cryopreserved-thawed embryo transfer in the GnRH agonist versus antagonist protocol. Iran J Reprod Med 2012; 10: 297-302.##Kalsum A, Jalali S. Role of hyperprolactinemia in fertility. Pak J Med Res 2002; 41: 94-100.پ##Neels JG, Badeanlou L, Hester KD, Samad F. Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis. J Biol Chem 2009; 284: 20692-20698.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Effects of administration of co-trimoxazole and folic acid on sperm quality and histological changes of testes in male rats</TitleF>
		<TitleE>اثر تجویز تحت حاد کوتریموکسازول و اسیدفولیک در کیفیت اسپرم و تغییرات بافت‌شناسی بیضه در موش صحرایی نر

</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: گزارش&#173;های زیادی در مورد اثرات مصرف طولانی مدت سولفاسالازین بر ناباروری مردان گزارش شده است، اگرچه اطلاعات دقیقی از تأثیر مصرف کوتریموکسازول بر کیفیت اسپرم وجود ندارد.
هدف: در این تحقیق به بررسی اثرات مصرف کوتریموکسازول و مصرف توأمان با اسیدفولیک بر کیفیت اسپرم در موش صحرایی نر پرداختیم.
موارد و روش&#173;ها: در این مطالعه تجربی، تعداد 136 سر موش صحرایی نر نژاد ویستار، به 9 گروه: کنترل، شم (دریافت&#173;کننده نرمال سالین)، اسید&#173;فولیک (1mg/kg/daily) و گروه&#173;های دریافت&#173;کننده داروی کوتریموکسازول (mg/kg 30 ,60 و 120) و اسید&#173;فولیک (1 mg/kg) به تنهایی یا به صورت توأمان به مدت 14 و 28 روز به صورت وریدی تقسیم شدند. در پایان روز 14 و 28 نمونه اسپرم تهیه و از نظر تعداد، تحرک و زنده بودن مورد بررسی قرار گرفت. نمونه بافت تثبیت شده بیضه نیز پس از رنگ&#173;آمیزی هماتوکسیلین- ائوزین از نظر تعداد سلول&#173;های لیدیگ، اسپرماتید و اسپرماتوسیت، عروق خونی و قطر لوله&#173;های اسپرم ساز زیر میکروسکوپ نوری مورد مطالعه قرار گرفت.
نتایج: تجویز کوتریموکسازول به مدت 14 و 28 روز سبب کاهش معنی&#173;دار در تعداد، تحرک و درصد اسپرم زنده در مقایسه با گروه کنترل شد (0.001 P&#60;)، همچنین دوزهای بالای کوتریموکسازول کاهش معنی&#173;داری در قطر لوله&#173;های اسپرم&#173;ساز و تعداد سلول&#173;های اسپرماتید و اسپرماتوسیت در مقایسه با گروه کنترل به همراه داشت (0.001 P&#60;). تجویز توأمان اسیدفولیک تا حدی این اثرات سوء بر کیفیت اسپرم و اثرات بر ساختاری بیضه در دوز&#173;های بالای کوتریموکسازول (mg/kg 60 و 120) را بهبود بخشید. (0.001 P&#60;).
نتیجه &#173;گیری: نتایج این پژوهش نشان داد داروی کوتریموکسازول سبب کاهش کیفیت اسپرم و اثرات سوء بر بافت بیضه می&#173;شود که مصرف توأمان اسید&#173;فولیک تا حدی این اثرات سوء را در موش صحرایی بهبود می&#173;بخشد. مکانیسم این فرآیند هنوز ناشناخته و نیازمند تحقیقات بیشتری است.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Male infertility has been reported following long-term sulfasalazine, however, the precise effects of co-trimoxazole on sperm quality is controversial.
Objective: In this study, we evaluated the effects of co-trimoxazole and its co-administration with folic acid on sperm quality and histological changes of testes in male rats.
Materials and Methods: In this experimental study, 136 male Wistar rats were divided into 9 groups: I (control), II (vehicle) received saline, III: received folic acid (1 mg/kg /daily i.p., and IV- IX received co-trimoxazole (30, 60, and 120 mg/kg/daily; i.p.)+folic acid (1 mg/kg/daily; i.p.) for 14 or 28 days. Sperm samples were obtained from each group at the end of 14th and 28th days. Sperm numbers, motility, and viability were evaluated on a hemocytometer. Hematoxylin and Eosin stained testes were done for evaluation ofthe number of Leydig cells, vascularity, spermatids, spermatocytes, and means of seminiferous tubules diameter under light microscopy.
Results: Co-trimoxazole treatment for either 14 or 28 days caused a significant decrease in the percentage of sperm number, motility, and viability (p&#60;0.001) compared to the control group. Also, high doses of co-trimoxazole caused a significant decrease in testes structural abnormalities means of seminiferous tubules diameter, spermatids, and spermatogonia) compared to the vehicle group (p&#60;0.001). Folic acid co-administration with co-trimoxazole partially reversed the decrease in sperm quality and structural abnormalities of high doses of co-trimoxazole (60 and 120 mg/kg/daily) (p&#60;0.001).
Conclusion: The data showed the adverse effects of co-trimoxazole on sperm quality and testes morphology which was protected partially by folic acid co-administration in rats. The underlying mechanism (s) needs further investigations.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>625</FPAGE>
			<TPAGE>634</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/12/42017/12/42017/12/42017/12/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/9/13
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/12/42017/12/42017/12/42017/12/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/9/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>احسان</Name>
				<MidName></MidName>
				<Family>سالارکیا</Family>
				<NameE>Ehsan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Salarkia</FamilyE>
				<Organizations>
				<Organization>Department of Biology, Karaj Branch, Islamic Azad University, Karaj, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>gsepehri@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>غلامرضا</Name>
				<MidName></MidName>
				<Family>سپهری</Family>
				<NameE>Gholamreza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sepehri</FamilyE>
				<Organizations>
				<Organization>Kerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>gsepehri@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>پروین</Name>
				<MidName></MidName>
				<Family>تراب زاده</Family>
				<NameE>Parvin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Torabzadeh</FamilyE>
				<Organizations>
				<Organization>Kerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>gsepehri@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>جلیل</Name>
				<MidName></MidName>
				<Family>آبشناس</Family>
				<NameE>Jalil</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abshenas</FamilyE>
				<Organizations>
				<Organization>Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>gsepehri@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>آرزوی</Name>
				<MidName></MidName>
				<Family>صابری</Family>
				<NameE>Arezoo</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Saberi</FamilyE>
				<Organizations>
				<Organization>Kerman Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>gsepehri@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Co-trimoxazole</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Folic acid</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Testis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Sperm quality</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Rats.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کوتریموکسازول</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اسیدفولیک</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بیضه</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کیفیت اسپرم</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>موش صحرایی.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Winters BR, Walsh TJ. The epidemiology of male infertility. Urol Clin North Am 2014; 41: 195-204.##Onyije FM. Drug: a major cause of infertility in the male. Asian J Mad Pharm Res 2012; 2: 30-37.##Sharma R, Biedenharn KR, Fedor JM, Agarwal A. Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol 2013; 11: 66.##Olayemi FO. A review on some causes of male infertility. Afr J Biotechnol 2010; 9: 2834-2842.##Pajovic B, Radojevic N, Vukovic M, Stjepcevic A. Semen analysis before and after antibiotic treatment of asymptomatic chlamydia-and ureaplasma-related pyospermia. Andrologia 2013; 45: 266-271.##Palomino JC, Martin A. The potential role of trimethoprim-sulfamethoxazole in the treatment of drug-resistant tuberculosis. Future Microbiol 2016; 11: 539-347.##Oputiri D, Elias A. Impact of co-administered lopinavir/ritonavir and sulfamethoxazole/trimethoprim on reproductive indices of male albino rats. Am J Pharmacol Sci 2014; 2: 93-99.##Merino G, Carranza-Lira S. Infection and male infertility: effect of different antibiotic regimens on semen quality. Arch Androl 1995; 35: 209-212.##Ragni G, Bianchi Porro G, Ruspa M, Barattini G, Lombardi C, Petrillo M. Abnormal semen quality and low serum testosterone in men with inflammatory bowel disease treated for a long time with sulfasalazine. Andrologia 1984; 16: 162-167.##Hargreaves CA, Rogers S, Hills F, Rahman F, Howell RJ, Homa ST. Effects of co-trimoxazole, erythromycin, amoxycillin, tetracycline and chloroquine on sperm function in vitro. Hum Reprod 1998; 13: 1878-1886.##Azizollahi GH, Azizollahi S, Babaei H, Kianinejad MA, Baneshi MR, Nematollahi-mahani SN. Effects of zinc sulfate and folic acid co-administration on sperm parameters, protamine content and acrosomal integrity of varicocelectomized patients. Iran J Reprod Med 2013: 37.##Lambrot R, Xu C, Saint-Phar S, Chountalos G, Cohen T, Paquet M, et al. Low paternal dietary folate alters the mouse sperm epigenome and is associated with negative pregnancy outcomes. Nat Commun 2013; 4: 1-13.##Chan D, McGraw S, Klein K, Wallock LM, Konermann C, Plass C, et al. Stability of the human sperm DNA methylome to folic acid fortification and short-term supplementation. Hum Reprod 2017; 32: 272-283.##Agarwal A, Sharma RK, Sharma R, Assidi M, Abuzenadah AM, Alshahrani S, et al. Characterizing semen parameters and their association with reactive oxygen species in infertile men. Reprod Biol Endocrinol 2014; 12: 33.##Mendiola J, Torres-Cantero AM, Vioque J, Moreno-Grau JM, Ten J, Roca M, et al. A low intake of antioxidant nutrients is associated with poor semen quality in patients attending fertility clinics. Fertil Steril 2010; 93: 1128-1133.##Ross C, Morriss A, Khairy M, Khalaf Y, Braude P, Coomarasamy A, et al. A systematic review of the effect of oral antioxidants on male infertility. Reprod Biomed Online 2010; 20: 711-723.##Noda Y, Yamada K, Furukawa H, Nabeshima T. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. Br J Pharmacol 1995; 116: 2531-2537.##Baki ME, Miresmaili SM, Pourentezari M, Amraii E, Yousefi V, Spenani HR, et al. Effects of silver nano-particles on sperm parameters, number of Leydig cells and sex hormones in rats. Iran J Reprod Med 2014; 12: 139144.##Babaei H, Abshenas J. Zinc therapy improves adverse effects of long term administration of copper on epididymal sperm quality of rats. Iran J Reprod Med 2013; 11: 577-582.##Liu Y, O'Flaherty C. In vivo oxidative stress alters thiol redox status of peroxiredoxin 1 and 6 and impairs rat sperm quality. Asian J Androl 2017; 19: 73-79.##Sellami A, Chakroun N, Ben Zarrouk S, Sellami H, Kebaili S, Rebai T, et al. Assessment of chromatin maturity in human spermatozoa: useful aniline blue assay for routine diagnosis of male infertility. Adv Urol 2013; 2013: 578631.##Yang Z, Yin Y, Guo Y, Zhu J. Effects of water deprivation induced dehydration on the rat rete testis: a morphometric study. J North Sichuan Med Coll 2013; 28: 207-210.##Mutalip SSM, Surindar Singh GK, Mohd Shah A, Mohamad M, Mani V, Hussin SN. Histological changes in testes of rats treated with testosterone, nandrolone, and stanozolol. Iran J Reprod Med 2013; 11: 653-658.##Crotty KL, May R, Kulvicki A, Kumar D, Neal DE Jr. The effect of antimicrobial therapy on testicular aspirate flow cytometry. J Urol 1995; 153: 835-858.##Cosentino MJ, Chey WY, Takihara H, Cockett AT. The effects of sulfasalazine on human male fertility potential and seminal prostaglandins. J Urol 1984; 132: 682-686.##White IG. The toxicity of some antibacterials for bull, ram, rabbit and human spermatozoa. Aust J Exp Biol Med Sci 1954; 32: 41-48.##Lange D, Schirren C. Studies on the influence of trimethoprim/sulfamethoxazole on the quality of sperm in andrologic patients and a contribution to the pharmacological testing of a drug on the spermatogenetic activity of the testis. Z Hautkr 1974; 49: 863-878.##Ebisch IM, Pierik FH, De Jong FH, Thomas CM, Steegers-theunissen RP. Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men? Int J Androl 2006; 29: 339-345.##Young SS, Eskenazi B, Marchetti FM, Block G, Wyrobek AJ. The association of folate, zinc and antioxidant intake with sperm aneuploidy in healthy non-smoking men. Hum Reprod 2008; 23: 1014-1022.##Bistulfi G, Vandette E, Matsui S, Smiraglia DJ. Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells. BMC Biol 2010; 8: 6.##Stover PJ. Physiology of folate and vitamin B12 in health and disease. Nutr Rev 2004; 62: S3-12.##Wong WY, Thomas CM, Merkus JM, Zielhuis GA, Steegers-Theunissen RP. Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril 2000; 73: 435-442.##Swayne BG, Kawata A, Behan NA, Williams A, Wade MG, MacFarlane AJ, et al. Investigating the effects of dietary folic acid on sperm count, DNA damage and mutation in Balb/c mice. Mutat Res 2012; 737: 1-7.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The effect of vitamin E and aspirin on the uterine artery blood flow in women with recurrent abortion: A single-blind randomized controlled trial</TitleF>
		<TitleE>اثر ویتامین E و آسپرین بر جریان خون شریان رحمی در زنان مبتلا به سقط مکرر</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: سقط خود&#173;بخودی مکرر شیوع بالایی دارد. اتیولوژی آن در 40-30% موارد ناشناخته است. اما یکی از علل آن بالا بودن مقاومت شریان رحمی می&#173;باشد.
هدف: هدف از انجام این پژوهش بررسی تأثیر درمان با ویتامین E و آسپیرین بر میزان جریان خون رحمی در زنان با سقط مکرر به علت اختلال در خونرسانی رحمی است.
موارد و روش&#173;ها: این مطالعه از نوع کارآزمایی بالینی تصادفی شده بر روی 99 زن با ایندکس جریان خون رحمی((Pulsatility Index (PI) بیشتر از 5/2 و دارای سابقه بیش از 2 نوبت سقط انجام گرفت. بیماران بصورت تصادفی به سه گروه تقسیم شدند (دریافت&#173;کننده آسپیرین، ویتامین E و آسپیرین به همراه ویتامین E). پس از 2 ماه ایندکس جریان خون (PI) رحمی مقایسه شد.
نتایج: هر سه رژیم درمانی باعث تقویت جریان خون رحمی و کاهش معنی&#173;دار میانگین PI شریان رحمی شدند. در بیماران دریافت&#173;کننده ویتامین E به همراه آسپیرین کمترین میزان PI در میان گروه&#173;ها مشاهده شد (001/0&#62;p).
نتیجه&#173; گیری: نتیجه مطالعه حاضر نشان داد که ویتامین E و آسپیرین و به خصوص تجویز ترکیبی آنها سبب بهبود جریان خون رحمی در زنان مبتلا به سقط مکرر به علت اختلال در خونرسانی رحمی می&#173;شود. انجام مطالعات دقیق&#173;تری برای بررسی اثر درمانی داروهای فوق بر نتایج بارداری و پیشگیری از سقط مکرر ضروری به نظر می&#173;رسد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Recurrent spontaneous abortion has high incidence rate. The etiology is unknown in 30-40%. However high uterine artery resistance is accounted as one of the recurrent abortion reasons.
Objective: The objective of the current study was to determine the impacts of vitamin E and aspirin on the uterine artery blood flow in women having recurrent abortions due to impaired uterine blood flow.
Materials and Methods: This randomized clinical trial was conducted on 99 women having uterine pulsatility index (PI) more than 2.5 and the history of more than two times abortions. The candidates were categorized into three groups; receiving aspirin, only vitamin E, and aspirin+vitamin E. After 2 months, uterine PIs were compared with each other.
Results: All drug regimens caused an enhancement in uterine perfusion with a significant decline in uterine artery PI value. The women receiving vitamin E in accompanied with aspirin had the least mean PI of the uterine artery (p&#60;0.001). The total average PI score of the right and left uterine arteries in groups receiving vitamin E in accompanied with aspirin was lower than the two counterparts significantly (p&#60;0.001).
Conclusion: Vitamin E, aspirin and especially their combination are effective in improving uterine artery blood flow in women with recurrent abortion due to impaired uterine blood flow. More well-designed studies are needed to find out whether the enhancement of uterine perfusion may lead to a better pregnancy outcome.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>635</FPAGE>
			<TPAGE>640</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/12/42017/12/42017/12/42017/12/42017/12/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/9/13
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/12/42017/12/42017/12/42017/12/42017/12/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/9/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>الهه</Name>
				<MidName></MidName>
				<Family>مصداقی نیا</Family>
				<NameE>Elaheh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mesdaghinia</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Kashan University of Medical Sciences, Kashan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>banafshe57@hotmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>بهناز</Name>
				<MidName></MidName>
				<Family>محمد ابراهیمی</Family>
				<NameE>Behnaz</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mohammad-Ebrahimi</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Kashan University of Medical Sciences, Kashan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>banafshe57@hotmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>فاطمه</Name>
				<MidName></MidName>
				<Family>فروزانفرد</Family>
				<NameE>Fatemeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Foroozanfard</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Kashan University of Medical Sciences, Kashan, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>banafshe57@hotmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>حمیدرضا</Name>
				<MidName></MidName>
				<Family>بنفشه</Family>
				<NameE>Hamid Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Banafshe</FamilyE>
				<Organizations>
				<Organization>Physiology Research Center, Kashan University of Medical Sciences, Kashan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>banafshe57@hotmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Recurrent abortion</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Aspirin</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Vitamin E</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Pulsatility index</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سقط مکرر</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آسپیرین</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ویتامین E و ایندکس جریان خون رحمی.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Wilkinson D, Tholandi M, Ramjee G, Rutherford GW. Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomized controlled trials including more than 5000 women. Lancet Infect Dis 2002; 2: 613-617.##Van Damme L, Ramjee G, Alary M, Vuylsteke B, Chandeying V, Rees H, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002; 360: 971-977.##Ragheb A, Attia A, Eldin WS, Elbarbry F., Gazarin S, Shoker A. The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent, against renal injury: a review. Saudi J Kidney Dis Transpl 2009; 20: 741-752.##Al-Zahrani S, Mohany M, Kandeal S, Badr G. Thymoquinone and vitamin E supplementation improve the reproductive characteristics of heat stressed male mice. J Med Plants Res 2012; 6: 493-499.##Saheera K, Sha'ban M, Abdul Rahman S. Effects on mouse spermatogenesis and DNA fragmentation following exposure to cyclophosphamide and thymoquinone. Eur Int J Sci Technol 2013; 2: 119-136.##Kanter M. Thymoquinone reestablishes spermatogenesis after testicular injury caused by chronic toluene exposure in rats. Toxicol Ind Health 2011; 27: 155-166.##Lina S, Hashida NH, Eliza H. Role of Habbatus sauda towards the histological features of nicotine treated male rats seminal vesicle and prostate gland. Biomed Res 2014; 25: 11-18.##Hughes LM, Griffith R, Carey A, Butler T, Donne SW, Beagley KW, et al. The spermostatic and microbicidal actions of quinones and maleimides: toward a dual-purpose contraceptive agent. Mol Pharmacol 2009; 76: 113-124.##Alhimaidi AR. Thymoquinone treatment of intracytoplasmic sperm injection (ICSI) compared to in vitro fertilization of mice oocytes and their development in vitro. Adv Mol Med 2005; 1: 119-123.##Kamarzaman S, Wahab AY, Rahman SA. Effects of thymoquinone supplementation on cyclophosphamide toxicity of mouse embryo in vitro. Glob Vet 2014; 12: 80-90. 11. World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th Ed. World health organization publication, china; 2010.##Jamalzadeh L, Ghafoori H, Sariri R, Rabuti H, Nasirzade J, Hasani H, et al. Cytotoxic effects of some common organic solvents on MCF-7, RAW-264.7 and human umbilical vein endothelial cells. Avicenna J Med Biochem 2016; 4 e33453.##Hossain S, Sikes-Thurston E, Leppla SH, Wein AN. Thymoquinone as a novel antibiotic and chemotherapeutic agent: a natural therapeutic approach on Staphylococcus aureus, Bacillus anthracis, and four NCI-60 cancer cell lines. J Exp Second Sci 2012; 19: 1-4.##Guthrie HD, Welch GR. Effects of reactive oxygen species on sperm function. Theriogenology 2012; 78: 1700-1708.##Gali-Muhtasib HU, Kheir WG, Kheir LA, Darwiche N, Crooks PA. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs 2004; 15: 389-399.##Banerjee S, Kaseb AO, Wang Z, Kong D, Mohammad M, Padhye S, et al. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Res 2009; 69: 5575-5583.##Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, et al. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer 2010; 62: 938-946.##Malkovsky M, Newell A, Dalglish AG. Inactivation of HIV by Nonoxynol-9. Lancet 1988; 1: 645.##Azeiz AZ A, Saad AH, Darweesh MF. Efficacy of Thymoquinone against Vaginal Candidiasis in Prednisolone-induced Immunosuppressed Mice. J Am Sci. 2013; 9: 155-159.##Rooney S, Ryan MF. Effects of Alpha-hederin and thymoquinone, constituents of Nigella sativa on human cancer cell lines. Anticancer Res 2005; 25: 2199-2204.##Gali-Muhtasib HU, Abou Kheir WG, Kheir LA, Darwiche N, Crooks PA. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anti-cancer Drugs 2004; 15: 389-399.##Worthen DR, Ghosheh OA, Crooks PA. The in vitro anti-tumor activity of some crude and purified components of black seed, Nigella sativa L. Anticancer Res 1997; 18: 1527-1532.##Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003; 17: 299-305.##Forouzanfar F, Bazzaz BS, Hosseinzadeh H. Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. Iran J Basic Med Sci 2014; 17: 929-938.##Tonkal A. In vitro antitrichomonal effect of Nigella sativa aqueous extract and wheat germ agglutinin. Med Sci 2009; 16: 17-34.##Ruiz-Pesini E, Diez C, Lape-a AC, Pérez-Martos A, Montoya J, Alvarez E, et al. Correlation of sperm motility with mitochondrial enzymatic activities. Clin Chem 1998; 44:1616-1620.##Agnihotri SK, Agrawal AK, Hakim BA, Vishwakarma AL, Narender T, Sachan R, et al. Mitochondrial membrane potential (MMP) regulates sperm motility. In Vitro Cell Dev Biology-Anim 2016; 52: 953-960.##Barroso G, Taylor S, Morshedi M, Manzur F, Gavi-o F, Oehninger S. Mitochondrial membrane potential integrity and plasma membrane translocation of phosphatidylserine as early apoptotic markers: a comparison of two different sperm subpopulations. Fertil Steril 2006; 85: 149-154.##Kasai T, Ogawa K, Mizuno K, Nagai S, Uchida Y, Ohta S, et al. Relationship between sperm mitochondrial membrane potential, sperm motility, and fertility potential. Asian J Androl 2002; 4: 97-104.##Paoli D, Gallo M, Rizzo F, Baldi E, Francavilla S, Lenzi A, et al. Mitochondrial membrane potential profile and its correlation with increasing sperm motility. Fertil Steril 2011; 95: 2315-2319.##Piasecka M, Kawiak J. Sperm mitochondria of patients with normal sperm motility and with asthenozoospermia: morphological and functional study. Folia Histochem Cytobiol 2003; 41: 125-139.##Sousa AP, Amaral A, Baptista M, Tavares R, Caballero Campo P, Caballero Peregrín P, et al. Not all sperm are equal: functional mitochondria characterize a subpopulation of human sperm with better fertilization potential. PloS One 2011; 6: e18112.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Thymoquinone as a natural spermostatic substance in reproductive medicine: An experimental study</TitleF>
		<TitleE>تیموکینون ماده ای طبیعی و متوقف کننده حرکت اسپرم در طب باروری: یک مطالعه تجربی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: نونوکسینول 9 یک سورفاکتانت غیر یونی است که بخاطر اثرات کشندگی آن بر اسپرم بطور وسیع مورد استفاده است. بدلیل آنکه نونوکسینول 9 ممکن است سبب تخریب احتمالی بافت&#173;های پوششی دستگاه تناسلی زن شود، یافتن ترکیبات جدید متوقف&#173;کننده حرکت اسپرم ضروری است.
هدف: هدف از این مطالعه ارزیابی اثرات تیموکینون به عنوان یک ماده بالقوه متوقف کننده حرکت اسپرم، بر روی حرکت و بقا اسپرم انسان بود.
موارد و روش&#173;ها: در این مطالعه تجربی، اثرات مقادیر 5، 10، 20، 50، 100 میکروگرم بر میلی&#173;لیتر، 1 و 10 میلی&#173;گرم بر لیتر تیموکینون بر نمونه&#173;های مایع منی نوروموزواسپرم مورد بررسی قرار گرفت. تحرک و بقا اسپرمی در کسرهایی از نمونه مایع منی که فاقد و یا حاوی تیموکینون بودند، مقایسه شدند. 32 نمونه مایع منی جهت ارزیابی اثرات تیموکینون بر تغییرات غشاء میتوکندری تحت تاثیر 50 میکروگرم بر میلی&#173;لیتر تیموکینون قرار گرفتند. بررسی فلوسیتومتری پس از رنگ آمیزی اسپرم&#173;ها با &#160;JC-1انجام پذیرفت.
نتایج: مقادیر بالای 20 میکروگرم بر میلی&#173;لیتر تیموکینون تمامی اسپرمها را بالاخره در محیط کشت متوقف می&#173;کنند. افزودن میزان 50 میکروگرم بر میلی&#173;لیتر تیموکینون، درصد اسپرم&#173;های زنده را بطور معنی&#173;دار کاهش نمی&#173;دهد و نتایج فلوسیتومتری نشانگر آن هستند که این میزان از تیموکینون می&#173;تواند پتانسیل غشاء داخلی میتوکندری را کاهش دهد.
نتیجه&#173; گیری: تیموکینون می&#173;تواند بدون کاهش جمعیت اسپرم&#173;های زنده، حرکت اسپرم&#173;ها را در محیط کشت متوقف نماید. بنابراین، تیموکینون را می&#173;توان به عنوان یک ماده شیمیایی جدید طبیعی که توانایی بالقوه در متوقف کردن اسپرم&#173;ها دارد، مورد توجه قرار داد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Nonoxynol-9 a nonionic surfactant is widely used for its spermicidal effects. Finding new sperm immobilizing agents is necessary because Nonoxynol-9 damages the tissues of female reproductive system.
Objective: The aim of this study was to evaluate the effects of Thymoquinone (TQ) as a potential spermostatic compound on the motility and viability of human spermatozoa.
Materials and Methods: In this experimental study, the effects of 5, 10, 20, 50, 100 &#956;g/ml, 1 and 10 mg/ml of TQ on normozoospermic semen samples were investigated. Sperm motility and viability were compared between untreated and TQ-treated aliquots of each semen sample. To evaluate the effects of TQ on the alteration of mitochondrial membrane potential (MMP), 32 semen samples were examined using 50 &#956;g/ml of TQ. Flow cytometric analysis was performed after staining of spermatozoa with JC-1.
Results: Doses above 20 &#956;g/ml of TQ could eventually immobilize all spermatozoa in culture medium. Adding 50 &#956;g/ml of TQ did not significantly diminish the percentage of viable spermatozoa and flow cytometry results revealed that this amount of TQ could decrease sperm MMP.
Conclusion: TQ could discontinue the movement of sperm cells in medium without reducing the population of live spermatozoa. It is more likely that TQ exerts its spermostatic action by mitigating the MMP of spermatozoa. Therefore, TQ could be considered as a potential new natural spermostatic chemical</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>641</FPAGE>
			<TPAGE>648</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/12/42017/12/42017/12/42017/12/42017/12/42017/12/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/9/13
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/12/42017/12/42017/12/42017/12/42017/12/42017/12/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/9/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>فرهاد</Name>
				<MidName></MidName>
				<Family>گلشن ایرانپور</Family>
				<NameE>Farhad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Golshan Iranpour</FamilyE>
				<Organizations>
				<Organization>Department of Anatomical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>خاطره</Name>
				<MidName></MidName>
				<Family>فاضلیان</Family>
				<NameE>Khatereh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fazelian</FamilyE>
				<Organizations>
				<Organization>Department of Anatomical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>غلامرضا</Name>
				<MidName></MidName>
				<Family>دشتی</Family>
				<NameE>Gholam Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Dashti</FamilyE>
				<Organizations>
				<Organization>Department of Anatomical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>dashti@med.mui.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Nigella sativa</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Sperm immobilizing agents</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Sperm motility</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Thymoquinone</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سیاه دانه</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مواد متوقف کننده اسپرم</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>حرکت اسپرم</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تیموکینون.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Wilkinson D, Tholandi M, Ramjee G, Rutherford GW. Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomized controlled trials including more than 5000 women. Lancet Infect Dis 2002; 2: 613-617.##Van Damme L, Ramjee G, Alary M, Vuylsteke B, Chandeying V, Rees H, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002; 360: 971-977.##Ragheb A, Attia A, Eldin WS, Elbarbry F., Gazarin S, Shoker A. The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent, against renal injury: a review. Saudi J Kidney Dis Transpl 2009; 20: 741-752.##Al-Zahrani S, Mohany M, Kandeal S, Badr G. Thymoquinone and vitamin E supplementation improve the reproductive characteristics of heat stressed male mice. J Med Plants Res 2012; 6: 493-499.##Saheera K, Sha'ban M, Abdul Rahman S. Effects on mouse spermatogenesis and DNA fragmentation following exposure to cyclophosphamide and thymoquinone. Eur Int J Sci Technol 2013; 2: 119-136.##Kanter M. Thymoquinone reestablishes spermatogenesis after testicular injury caused by chronic toluene exposure in rats. Toxicol Ind Health 2011; 27: 155-166.##Lina S, Hashida NH, Eliza H. Role of Habbatus sauda towards the histological features of nicotine treated male rats seminal vesicle and prostate gland. Biomed Res 2014; 25: 11-18.##Hughes LM, Griffith R, Carey A, Butler T, Donne SW, Beagley KW, et al. The spermostatic and microbicidal actions of quinones and maleimides: toward a dual-purpose contraceptive agent. Mol Pharmacol 2009; 76: 113-124.##Alhimaidi AR. Thymoquinone treatment of intracytoplasmic sperm injection (ICSI) compared to in vitro fertilization of mice oocytes and their development in vitro. Adv Mol Med 2005; 1: 119-123.##Kamarzaman S, Wahab AY, Rahman SA. Effects of thymoquinone supplementation on cyclophosphamide toxicity of mouse embryo in vitro. Glob Vet 2014; 12: 80-90. 11. World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th Ed. World health organization publication, china; 2010.##Jamalzadeh L, Ghafoori H, Sariri R, Rabuti H, Nasirzade J, Hasani H, et al. Cytotoxic effects of some common organic solvents on MCF-7, RAW-264.7 and human umbilical vein endothelial cells. Avicenna J Med Biochem 2016; 4 e33453.##Hossain S, Sikes-Thurston E, Leppla SH, Wein AN. Thymoquinone as a novel antibiotic and chemotherapeutic agent: a natural therapeutic approach on Staphylococcus aureus, Bacillus anthracis, and four NCI-60 cancer cell lines. J Exp Second Sci 2012; 19: 1-4.##Guthrie HD, Welch GR. Effects of reactive oxygen species on sperm function. Theriogenology 2012; 78: 1700-1708.##Gali-Muhtasib HU, Kheir WG, Kheir LA, Darwiche N, Crooks PA. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs 2004; 15: 389-399.##Banerjee S, Kaseb AO, Wang Z, Kong D, Mohammad M, Padhye S, et al. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Res 2009; 69: 5575-5583.##Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, et al. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer 2010; 62: 938-946.##Malkovsky M, Newell A, Dalglish AG. Inactivation of HIV by Nonoxynol-9. Lancet 1988; 1: 645.##Azeiz AZ A, Saad AH, Darweesh MF. Efficacy of Thymoquinone against Vaginal Candidiasis in Prednisolone-induced Immunosuppressed Mice. J Am Sci. 2013; 9: 155-159.##Rooney S, Ryan MF. Effects of Alpha-hederin and thymoquinone, constituents of Nigella sativa on human cancer cell lines. Anticancer Res 2005; 25: 2199-2204.##Gali-Muhtasib HU, Abou Kheir WG, Kheir LA, Darwiche N, Crooks PA. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anti-cancer Drugs 2004; 15: 389-399.##Worthen DR, Ghosheh OA, Crooks PA. The in vitro anti-tumor activity of some crude and purified components of black seed, Nigella sativa L. Anticancer Res 1997; 18: 1527-1532.##Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003; 17: 299-305.##Forouzanfar F, Bazzaz BS, Hosseinzadeh H. Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. Iran J Basic Med Sci 2014; 17: 929-938.##Tonkal A. In vitro antitrichomonal effect of Nigella sativa aqueous extract and wheat germ agglutinin. Med Sci 2009; 16: 17-34.##Ruiz-Pesini E, Diez C, Lape-a AC, Pérez-Martos A, Montoya J, Alvarez E, et al. Correlation of sperm motility with mitochondrial enzymatic activities. Clin Chem 1998; 44:1616-1620.##Agnihotri SK, Agrawal AK, Hakim BA, Vishwakarma AL, Narender T, Sachan R, et al. Mitochondrial membrane potential (MMP) regulates sperm motility. In Vitro Cell Dev Biology-Anim 2016; 52: 953-960.##Barroso G, Taylor S, Morshedi M, Manzur F, Gavi-o F, Oehninger S. Mitochondrial membrane potential integrity and plasma membrane translocation of phosphatidylserine as early apoptotic markers: a comparison of two different sperm subpopulations. Fertil Steril 2006; 85: 149-154.##Kasai T, Ogawa K, Mizuno K, Nagai S, Uchida Y, Ohta S, et al. Relationship between sperm mitochondrial membrane potential, sperm motility, and fertility potential. Asian J Androl 2002; 4: 97-104.##Paoli D, Gallo M, Rizzo F, Baldi E, Francavilla S, Lenzi A, et al. Mitochondrial membrane potential profile and its correlation with increasing sperm motility. Fertil Steril 2011; 95: 2315-2319.##Piasecka M, Kawiak J. Sperm mitochondria of patients with normal sperm motility and with asthenozoospermia: morphological and functional study. Folia Histochem Cytobiol 2003; 41: 125-139.##Sousa AP, Amaral A, Baptista M, Tavares R, Caballero Campo P, Caballero Peregrín P, et al. Not all sperm are equal: functional mitochondria characterize a subpopulation of human sperm with better fertilization potential. PloS One 2011; 6: e18112.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The effects of Salvia officinalis L. on granulosa cells and in vitro maturation of oocytes in mice</TitleF>
		<TitleE>اثر مریم گلی بر روی سلول های گرانولوزا و اووسیت های کشت داده شده موش:  یک مطالعه کاربردی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: مریم گلی (Salvia officinalis L) جهت درمان از زمان&#173;های گذشته استفاده می&#173;شده است اما درباره اثرات این گیاه بر روی دستگاه تناسلی سالم اطلاعات کمی وجود دارد. بررسی اثرات سمی مریم گلی بر روی سلول&#173;های گرانولوزا و بلوغ اووسیت&#173;ها مورد بررسی قرار گرفت.
هدف: در تحقیق حاضر اثرات این گیاه بر روی سلول&#173;های گرانولوزا و اووسیت&#173;های طبیعی بررسی می&#173;شود.
موارد و روش&#173;ها: سلول&#173;های گرانولوزا و اووسیت&#173;ها از تخمدان&#173;های تحریک شده برای تخمک&#173;گذاری موش&#173;های نابالغ استخراج شدند. 24 ساعت بعد سلول&#173;ها با دوز&#173;های 0، 10، 50 ،100، 500 و 1000 میکرو&#173;گرم در هر میلی&#173;لیتر عصاره هیدروالکلی مریم گلی تیمار شدند. زیستایی، تراکم کروماتین، سطح استردیول و پروژسترون، میزان لیپید، اپوپتوز و فعالیت الکالین فسفاتاز سلول&#173;های گرانولوزا اندازه&#173;گیری شد. مراحل مختلف بلوغ تخمک&#173;ها شامل ژرمینال وزیکول (GV)، گسستگی ژرمینال وزیکول (GVBD) و متافاز &#160;(MII)بررسی شد.
نتایج: نتایج بیانگر سمیت دوزهای&#956;g/ml &#160;500 و 1000 عصاره بود. اکثر سلول&#173;های گرانولوزا در دوز &#956;g/ml 100 در مراحل اولیه اپوپتوز بودند اما در دوز &#956;g/ml 500 مرگ سلولی مشاهده شد. سطح پروژسترون در دوز&#956;g/ml &#160;100 و بالاتر از آن کاهش یافت ولی سطح استردیول و فعالیت الکالین فسفاتاز در این دوزها افزایش نشان داد. قطرات لیپیدی موجود درسلول&#173;های گرانولوزا در کلیه دوزها بخصوص &#956;g/ml 500 و 1000 از کاهش چشمگیری برخوردار بود. هسته و سیتوپلاسم اووسیت&#173;ها در تمامی دوزها به سمت متراکم شدن پیش رفت و از شدت میوز آن&#173;ها کاسته شد.
نتیجه&#173; گیری: دوزهای بالای عصاره هیدروالکلی مریم گلی زیستایی، تکثیر، ترشح سلول&#173;های گرانولوزا و رسیدگی اووسیت&#173;ها را مهار می&#173;کند.
&#160;</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Salvia officinalis L. has been used since ancient times but there are little data about effects of this herb on normal reproductive cells.
Objective: To investigate the toxicity effects of Salvia officinalis L. on granulosa cells (GCs) and maturation of oocytes.
Materials and Methods: GCs and oocytes were extracted from superovulated ovaries of immature mice. The cells were treated with concentrations of 10, 50, 100, 500, and 1000 &#956;g/ml of Salvia officinalis hydroalcoholic extracts and compared with the control culture. Bioviability, chromatin condensation, estradiol and progesterone concentrations, lipid synthesis, apoptosis, and alkaline phosphatase activity of GCs were measured. In vitro maturation of oocytes by determination of different maturation stages of oocytes including germinal vesicle, germinal vesicle breaks down, and metaphase II were examined.
Results: The results revealed that 500 and 1000 &#956;g/ml concentrations of Salvia officinalis L. were toxic. The most of the GCs were in the early stages of apoptosis in 100 &#956;g/ml treated culture and cell death happened with 500 &#956;g/ml treatment. Progesterone concentration was reduced in 100 &#956;g/ml and higher doses but estradiol concentration and alkaline phosphatase showed opposite effects. The lipid droplets content of GCs reduced significantly in all groups especially in 500 and 1000 &#956;g/ml. Finally, oocyte&#8217;s nucleus and cytoplasm showed a high level of condensation, and meiosis rate reduced in all treated cultures.
Conclusion: Our findings suggested that higher dose of Salvia officinalis hydroalcoholic extracts inhibits, oocyte maturation, GCs bioviability, proliferation, and secretion.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>649</FPAGE>
			<TPAGE>660</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/12/42017/12/42017/12/42017/12/42017/12/42017/12/42017/12/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/9/13
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/12/42017/12/42017/12/42017/12/42017/12/42017/12/42017/12/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/9/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>ملیحه الزمان</Name>
				<MidName></MidName>
				<Family>منصفی</Family>
				<NameE>Malihezaman</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Monsefi</FamilyE>
				<Organizations>
				<Organization>Department of Biology, School of Sciences, Shiraz University, Shiraz, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>monsefi@susc.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>اکرم</Name>
				<MidName></MidName>
				<Family>نادی</Family>
				<NameE>Akram</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nadi</FamilyE>
				<Organizations>
				<Organization>Department of Biology, School of Sciences, Shiraz University, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>monsefi@susc.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>زینب</Name>
				<MidName></MidName>
				<Family>علی نژاد</Family>
				<NameE>Zeinab</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Alinejad</FamilyE>
				<Organizations>
				<Organization>Department of Biology, School of Sciences, Shiraz University, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>monsefi@susc.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Granulosa cell</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>In vitro maturation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Oocytes</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ovary</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Salvia officinalis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سلول گرانولوزا</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بلوغ ازمایشگاهی تخمک</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اووسیت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تخمدان</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مریم گلی.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Khalil R, Li ZG. Antimicrobial activity of essential oil of Salvia officinalis L. collected in Syria. Afr J Biotechnol 2011; 10: 8397-8402.##Walch SG, Tinzoh LN, Zimmermann BF, Stühlinger W, Lachenmeier DW. Antioxidant capacity and polyphenolic composition as quality indicators for aqueous infusions of Salvia officinalis L. (sage tea). Front Pharmacol 2011; 2: 79.##Khan A, Rehman NU, AlKharfy KM, Gilani AH. Antidiarrheal and antispasmodic activities of Salvia officinalis are mediated through activation of K+ channels. Bangladesh J Pharmacol 2011; 6: 111-116.##Ayatollahi SA, Shojaii A, Kobarfard F, Mohammadzadeh M, Choudhary MI. Two flavones from Salvia leriaefolia. Iran J Pharm Res 2009; 8: 179-184.##Hamidpour M, Hamidpour R, Hamidpour S, Shahlari M. Chemistry, pharmacology, and medicinal property of sage (salvia) to prevent and cure lllnesses such as obesity, diabetes, depression, dementia, lupus, autism. heart disease, and cancer. J Tradit Complement Med 2014; 4: 82-88.##Hadri AE, Gó mez del Rí o MA, Sanz J, Gonzá lez Coloma A, Idaomar M, Ribas Ozonas B, et al. Cytotoxic activity of á-humulene and transcaryophyllene from salvia officinalis in animal and human tumor cells. An R Acad Nac Farm 2010; 76: 343-356.##Jedinak A, Muckova M, Kostalova D, Maliar T, Masterova I. Antiprotease and antimetastatic activity of ursolic acid isolated from salvia officinalis. Z Naturforsch C 2006; 61: 777-782.##Deans SG, Simpson EJM. Antioxidants from Salvia officinalis. En: The Genus Salvia. Amsterdam: Kintzios; 2000. 185-192.##Lu Y, Foo LY. Antioxidant activities of polyphenols from sage (Salvia officinalis). Food Chem 2001; 75: 197-202.##Monsefi M, Abedian M, Azarbahram Z, Ashraf MJ. Salvia officinalis L. Induces alveolar bud growing in adult female rat mammary glands. Avicenna J Phytomed 2015; 5: 560-567.##Sohrabi M, Mohammadi Roushandeh A, Alizadeh Z, Vahidinia A, Vahabian M, Hosseini. Effect of a high fat diet on ovary morphology, in vitro development, in vitro fertilisation rate and oocyte quality in mice. Singapore Med J 2015; 56: 573-579.##Dadoune JP, Mayaux MJ, Guihard-Moscato ML. Correlation between defects in chromatin condensation of human spermatozoa stained by aniline blue and semen characteristics. Andrologia 1988; 20: 211-217.##Kasibhatla S, Amarante-Mendes GP, Finucane D, Brunner T, Bossy-Wetzel E, Green DR. Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. CSH Protoc 2006; 2006: pii: pdb.prot4493.##Wang H, Wang H, Xiong W, Chen Y, Ma Q, Ma J, et al. Evaluation on the phagocytosis of apoptotic spermatogenic cells by sertoli cells in vitro through detecting lipid droplet formation by Oil Red O staining. Reproduction 2006; 132: 485-492.##Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516.##Roby MHH, Sarhan MA, Selim KAH, Khalel KI. Evaluation of antioxidant activity, total phenols and phenolic compounds in thyme (Thymus vulgaris L.), sage (Salvia officinalis L.), and marjoram (Origanum majorana L.) extracts. Ind. Crops Prod 2013; 43: 827-831.##Ososki AL, Kennelly EJ. Phytoestrogens: a review of the present state of research. Phytother Res 2003; 17: 845-869.##Nynca A, Jablonska O, Slomczynska M, Petroff BK, Ciereszko RE. Effects of phytoestrogen daidzein and estradiol on steroidogenesis and expression of estrogen receptors in porcine luteinized granulosa cells from large follicles. J Physiol Pharmacol 2009; 60: 95-105.##Nynca A, Nynca J, Wasowska B, Kolesarova A, Kołomycka A, Ciereszko RE. Effects of the phytoestrogen, genistein, and protein tyrosine kinase inhibitor–dependent mechanisms on steroidogenesis and estrogen receptor expression in porcine granulosa cells of medium follicles. Domest Anim Endocrinol 2013; 44: 10-18.##Tiemann U, Schneider F, Vanselow J, Tomek W. In vitro exposure of porcine granulosa cells to the phytoestrogens genistein and daidzein: effects on the biosynthesis of reproductive steroid hormones. Reprod Toxicol 2007; 24: 317-325.##Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, et al. Resveratrol-induced apoptosis in MCF‐7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl‐2 and NF-κB. Int J Cancer 2005; 115: 74-84.##Stochmalova A, Kadasi A, Alexa R, Sirotkin A. Plant molecules quercetin and resveratrol can affect ovarian cells and invert FSH action. Endocrine Abstracts 2014; 34: 318.##Xavier CP, Lima CF, Fernandes-Ferreira M, Pereira-Wilson C. Salvia fruticosa, salvia officinalis, and rosmarinic acid induce apoptosis and inhibit proliferation of human colorectal cell lines: the role in MAPK/ERK pathway. Nutr Cancer 2009; 61: 564-571.##Behroozi Moghadam S, Masoudi R, Monsefi M. Salvia officinalis L. induces apoptosis in mammary carcinoma cells through alteration of Bax to Bcl-2 ratio. Iran J Sci Technol 2016; 40.##Fukushima M, Tanaka S, Sato T, Hashimoto M. Morphological and biochemical studies on cultured human granulosa cells. Asia Oceania J Obstet Gynaecol 1983; 9: 473-479.##Adlercreutz H, Bannwart C, Wahala K, Makela T, Brunow G. Hase T. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993; 44: 147-153.##Santini SE, Basini G, Bussolati S, Grasselli F. The phytoestrogen quercetin impairs steroidogenesis and angiogenesis in swine granulosa cells in vitro. J Biomed Biotechnol 2009; 2009: 419891.##Bucci M, Murphy CR. Hormonal control of enzyme activity during the plasma membrane transformation of uterine epithelial cells. Cell Biol Int 2001; 25: 859-871.##Niknafs B, Afshar F, Dezfulian AR. The effects of different luteal support hormones on endometrial alkaline phosphatase activity and endometrial thickness in superovulated mice. Iran J Reprod Med 2010; 8: 18-23.##Janne OA. Progesterone action in mammalian uterus. Acta Obstet Gynecol Scand 1981; 101 (Suppl): 11-16.##Wober J, Weisswange I, Vollmer G. Stimulation of alkaline phosphatase activity in Ishikawa cells induced by various phytoestrogens and synthetic estrogens. J Steroid Biochem Mol Biol 2002; 83: 227-233.##Yoshida N, Mizuno K. Effect of physiological levels of phytoestrogens on mouse oocyte maturation in vitro. Cytotechnol 2012; 64: 241-247.##Hoskova K, Krivohlavkova L, Kadleckova L, Rajmon R, Drabek O, Jílek F. Biochanin a and daidze in influence meiotic maturation of pig oocytes in a different manner. Sci Agric Bohemica 2014; 45: 155-161.##Kang JT, Kwon DK, Park SJ, Kim SJ, Moon JH, Koo OJ, et al. Quercetin improves the in vitro development of porcine oocytes by decreasing reactive oxygen species levels. J Vet Sci 2013; 14: 15-20.##Orlovschi D, Miclea I, Zahan M, Miclea V, Pernes AJ. Quercetin efficacy on in vitro maturation of porcine oocytes. Anim Sci Biotechnol 2014; 47: 113-115.##Liu Y, He XQ, Huang X, Ding L, Xu L, Shen YT, et al. Resveratrol protects mouse oocytes from methylglyoxal-induced oxidative damage. PLoS One 2013; 8: e77960.##Mohaisen HA, Saad SA, Ferial KK. Effect of aqueous extract of medicago sativa and salvia officinalis mixture on hormonal, ovarian and uterine parameters in mature female mice. J Mater Environ Sci 2013; 4: 424-433.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Effect of Citrullus colocynthis hydro-alcoholic extract on hormonal and folliculogenesis process in estradiol valerate-induced PCOs rats model: An experimental study</TitleF>
		<TitleE>بررسی تجربی اثر عصاره هندوانه ابوجهل بر فرایند التهاب و استرس اکسیداتیو در رت های مبتلا به سندروم پلی کیستیک تخمدانی القاء شده توسط استرادیول</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: هندوانه ابوجهل (CCT) به عنوان یک عامل ضد&#173;دیابتی، ضد&#173;التهابی، و ضد&#173;اکسیدانی مورد استفاده قرار می&#173;گیرد. پلی&#173;کیستیک تخمدان (PCOS) یک اختلال تولید مثلی و متابولیکی می&#173;باشد که در آن سطح گنادوتروپین&#173;ها و هورمون&#173;های جنسی در خون به هم می&#173;ریزد.
هدف: هدف اصلی این مطالعه بررسی تاثیر عصاره هندوانه ابوجهل بر میانگین غلظت پلاسمایی هورمون&#173;های تستوسترون، LH, FSH و گلوکز و نیز مطالعه فرایند فولیکولوژنز در رت&#173;های پلی&#173;کیستیک می&#173;باشد.
موارد و روش&#173;ها: در این مطالعه تجربی چهل موش صحرایی نژاد ویستار به پنج گروه تقسیم شدند ( تعداد هر گروه 8). به گروه 1 (کنترل) فقط روغن کنجد به عنوان حلال استرادیول والرات تزریق شده، گروه 2 (شم) پس از پلی&#173;کیستیکی شدن در اثر تزریق 4 میلی&#173;گرم استرادیول والرات به ازای هر کیلوگرم وزن بدن به شکل درون عضلانی، سرم فیزیولوژی خورانده شده و در سه گروه تجربی پس از القاء پلی&#173;کیستیک در آن ها به مدت بیست روز به گروه 3، 50 میلی&#173;گرم عصاره گیاه، به گروه4، 50 میلی&#173;گرم متفورمین و به گروه 5 ترکیبی از 50 میلی&#173;گرم عصاره و متفورمین به ازای هر کیلوگرم وزن بدن خورانده شده است. سطح سرمی LH, FSH با استفاده از متد الیزا و سطح سرمی گلوکز با استفاده از شیوه اکسیداتیو اندازه&#173;گیری شد. مطالعه بافتی تخمدان به روش رنگ&#173;آمیزی هماتوکسیلین&#8211;ائوزین انجام شد
نتایج: در گروه&#173;های تجربی کاهش معنی&#173;داری در غلظت هورمون&#173;های تستوسترون و LH در مقایسه با گروه شم مشاهده شد، در حالی که غلظت FSH در گروه&#173;های تجربی و شم تفاوت معنی&#173;داری نداشت. بررسی&#173;های بافت&#173;شناسی نشان می&#173;دهد که در گروه&#173;های تجربی در مقایسه با گروه شم تعداد فولیکول&#173;های پره آنترال و آنترال و جسم زرد افزایش معنی&#173;داری نشان می&#173;دهد.
نتیجه&#173; گیری:بهبود قابل توجه تظاهرات هورمونی و بافتی در نمونه&#173;های پلی&#173;کیستیک می&#173;تواند ناشی از اثرات عصاره گیاه باشد. بنابراین عصاره این گیاه می&#173;تواند به عنوان داروی موثر در درمان پلی&#173;کیستیک به حساب آید.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Citrullus colocynthis (CCT) is used as the anti-diabetic and antioxidant agent. Polycystic ovarian syndrome (PCOS) is a reproductive disorder which level of gonadotropins and sexual hormones are imbalanced.
Objective: We evaluated the effect of CCT hydro-alcoholic extract on hormonal and folliculogenesis process in estradiol valerate-induced PCOs rats&#8217; model.
Materials and Methods: 40 female adult Wistar rats divided into five groups (n=8each: Group I (control) only injected by sesame oil as estradiol valerate solvent, group II (Sham) was orally received normal saline after estradiol valerate- induced polycystic ovarian syndrome (4 mg/rat estradiol valerate, intramuscularly), and three experimental groups, that after induction of PCOS within 60 days, received orally 50 mg/kg CCT extract (group III), 50mg/kg metformin (group IV), and CCT extract+ metformin (group V) for 20 days. The serum concentration level of luteinizing, testosterone and follicle stimulating hormones were measured using ELISA method and the serum concentration level of glucose were measured using the oxidative method (glucose meter). Histological study of ovary tissue carried out by hematoxylin-eosin staining.
Results: There was a significant reduction in luteinizing hormone and testosterone in III-V groups compared to Sham group, whereas follicle stimulating hormone in III-V groups was not significantly changed in comparison with Sham group. Histological investigations showed a significant increase in number of preantral and antral follicles and corpus luteum in the experimental groups compared to group II.
Conclusion: Marked improvement in hormonal and histological symptoms of PCOS may be due to CCT effects hence, CCT can potentially be considered as an effective drug for treatment of PCOS</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>661</FPAGE>
			<TPAGE>668</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2017/12/42017/12/42017/12/42017/12/42017/12/42017/12/42017/12/42017/12/4
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1396/9/13
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2017/12/42017/12/42017/12/42017/12/42017/12/42017/12/42017/12/42017/12/4
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1396/9/13
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>محمد حسین</Name>
				<MidName></MidName>
				<Family>برزگر بفروی</Family>
				<NameE>Mohammad Hossein</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Barzegar</FamilyE>
				<Organizations>
				<Organization>Department of Physiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>homayoun_khazai@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>همایون</Name>
				<MidName></MidName>
				<Family>خزعلی</Family>
				<NameE>Homayoun</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khazali</FamilyE>
				<Organizations>
				<Organization>Department of Physiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>homayoun_khazai@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>مهدی</Name>
				<MidName></MidName>
				<Family>کلانتر</Family>
				<NameE>Homayoun</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khazali</FamilyE>
				<Organizations>
				<Organization>Research and Clinical Center for Infertility, Yazd Reproduction Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>homayoun_khazai@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>آرزو</Name>
				<MidName></MidName>
				<Family>خرادمهر</Family>
				<NameE>Seyyed Mehdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kalantar</FamilyE>
				<Organizations>
				<Organization>Research and Clinical Center for Infertility, Yazd Reproduction Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>homayoun_khazai@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Polycystic ovary syndrome</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Gonadotropins hormones</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Follicugenesis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Rat Citrullus colocynthis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>پلی کیستیک تخمدان</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>رت نژاد ویستار</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Citrullus colocynthis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>التهاب.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Atiomo WU, El-Mahdi E, Hardiman P. Familial associations in women with polycystic ovary syndrome. Fertil Steril 2003; 80: 143-145.##Hassanzadeh Bashtian M, Emami SA, Mousavifar N, Esmaily HA, Mahmoudi M, Mohammadpoor AH. Evaluation of fenugreek (Trigonella Foenum-graceum L.), effects seeds extract on insulin resistance in women with polycystic ovarian syndrome. Iran J Pharm Res 2013; 12: 475-481.##Sheikhha MH, Kalantar SM. Diagnostic criteria in polycystic ovary syndrome. In: Polycystic ovary syndrome. Edited by: Allahbadia GN, Agrawal R. Anshan Ltd, Kent, UK. 2007, 27-32.##Rotterdam E, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25.##Munir, I, Yen HW, Geller DH, Torbati D, Bierden RM, Weitsman SR, et al. Insulin augmentation of 17α-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells. Endocrinology 2004; 145: 175-183.##Baillargeon JP, Carpentier A. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertil Steril 2007; 88: 886-893.##Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995; 10: 2705-2712.##Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 1992; 36: 105-111.##Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest 1976; 57: 1320-1329.##Van Santbrink EJ, Hop WC, Fauser BC. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 1997; 67: 452-458.##Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without the polycystic ovarian disease. J Clin Endocrinol Metab 1991; 73: 811-817.##Amorim CA, David A, Dolmans MM, Camboni A, Donnez J, Van Langendonckt A. Impact of freezing and thawing of human ovarian tissue on follicular growth after long-term xenotransplantation. J Assist Reprod Genet 2011; 28: 1157-1165.##Diamanti-Kandarakis E, Argyrakopoulou G, Economou F, Kandaraki E, Koutsilieris M. Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS). J Steroid Biochem Mol Biol 2008; 109: 242-246.##Nestler JE. Insulin regulation of human ovarian androgens. Hum Reprod 1997; 12 (suppl.): 53-62.##Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006-4011.##Sheikhha MH, Kalantar SM, Ghasemi N. Genetics of Polycystic Ovary Syndrome. Iran J Reprod Med 2007; 5: 1-5.##Mehdizadeh A, Sheikhha MH, Kalantar SM, Aali BS, Ghanei A. Mutation analysis of exon1 of bone morphogenetic protein-15 gene in Iranian patients with polycystic ovarian syndrome. Int J Reprod Biomed 2016; 14: 527-532.##Bendjeddou D, Lalaoui K, Satta D. Immunostimulating activity of the hot water-soluble polysaccharide extracts of Anacyclus pyrethrum, Alpinia galanga and Citrullus colocynthis. J Ethnopharmacol 2003; 88: 155-160.##Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-1447.##Abdel-Hassan IA, Abdel-Barry JA, Tarig Mohammeda S. The hypoglycaemic and antihyperglycaemic effect of Citrullus colocynthis fruit aqueous extract in normal and alloxan diabetic rabbits. J Ethnopharmacol 2000; 71: 325-330.##Ziyyat A, Legssyer A, Mekhfi H, Dassouli A, Serhrouchni M, Benjelloun W. Phytotherapy of hypertension and diabetes in oriental Morocco. J Ethnopharmacol 1997; 58: 45-54.##Benariba N, Djaziri R, Bellakhdar W, Belkacem N, Kadiata M, Malaisse WJ, et al. Phytochemical screening and free radical scavenging activity of Citrullus colocynthis seeds extracts. Asian Pac J Trop Biomed 2013; 3: 35-40.##Barth A, Müller D, Dürrling K. In vitro investigation of a standardized dried extract of Citrullus colocynthis on liver toxicity in adult rats. Exp Toxicol Pathol 2002; 54: 223-230.##Marzouk B, Marzouk Z, Fenina N, Bouraoui A, Aouni M. Anti-inflammatory and analgesic activities of Tunisian Citrullus colocynthis Schrad. Immature fruit and seed organic extracts. Eur Rev Med Pharmacol Sci 2011; 15: 665-672.##Huseini HF, Darvishzadeh F, Heshmat R, Jafariazar Z, Raza M, Larijani B. The clinical investigation of Citrullus colocynthis (L.) schrad fruit in treatment of Type II diabetic patients: a randomized, double blind, placebo-controlled clinical trial. Phytother Res 2009; 23:1186-1189.##Sharma A, Sharma P, Chaturvedi M, Joshi SC. Contraceptive efficacy of Citrullus colocynthis methanolic extract in male rats. Am J Phytomed clin Therap 2014; 2: 229-241.##Thakor AP, Patel AJ. Normalizing of estrous cycle in polycystic ovary syndrome (PCOS) induced rats with Tephrosia purpurea (Linn.) Pers. J Appli Natur Sci 2014; 1: 197-201.##Ullah N, Khan MA, Asif AH, Khan T, Ahmad W. Citrullus colocynthis failed to combat against renal derangements, in spite of its strong antioxidant properties. Acta Pol Pharm 2013; 70: 533-538.##Babaei H, Roshangar L, Sakhaee E, Abshenas J, Kheirandish R, Dehghani R. Ultrastructural and morphometrical changes of mice ovaries following experimentally induced copper poisoning. Iran Red Crescent Med J 2012; 14: 558-568.##Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352: 1223-1236.##Delazar A, Gibbons S, Kosari AR, Nazemiyeh H, Modarresi M, Nahar L, et al. Flavone C-glycosides and cucurbitacin glycosides from Citrullus colocynthis. DARU J Pharm Sci 2006; 14: 109-114.##Giwa S, Abdullah LC, Adam NM. Investigating &quot;Egusi&quot; (Citrullus colocynthis L.) seed oil as potential biodiesel feedstock. Energies 2010; 3: 607-618.##Wang Z, Zhai D, Zhang D, Bai L, Yao R, Yu J, et al. Quercetin Decreases Insulin Resistance in a Polycystic Ovary Syndrome Rat Model by Improving Inflammatory Microenvironment. Reprod Sci 2017; 24: 682-690.##Shah KN, Patel SS. Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome. Pharm Biol 2016; 54: 975-983.##Sivalingam VN, Myers J, Nicholas S, Balen AH, Crosbie EJ. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Hum Reprod Update 2014; 20: 853-868.##Nelson VL, Qin K-n, Rosenfield RL, Wood JR, Penning TM, Legro RS, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86: 5925-5933.##Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Ex Rev Mol Med 2008; 10.##Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999; 20: 535-582.##Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, Muller B. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab 2005; 90: 6014-6021.##González F, Rote N, Minium J, Kirwan JP. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-α release in obese women with polycystic ovary syndrome. J Endocrinol 2006; 188: 521-529.##Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.##Liang Y-C, Huang Y-T, Tsai S-H, Lin-Shiau S-Y, Chen C-F, Lin J-K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 1999; 20: 1945-1952.##Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Ther 2002; 96: 67-202.##Kim HP, Son KH, Chang HW, Kang SS. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 2004; 96: 229-245.##Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 2004; 10: 107-117.##Willis DS, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 1998; 83: 3984-3991.##Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab 2001; 86: 1318-1323.##Willis DS, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature Response to Luteinizing Hormone of Granulosa Cells from Anovulatory Women with Polycystic Ovary Syndrome: Relevance to Mechanism of Anovulation. J Clin Endocrinol Metab 1998; 83: 3984-3991.##Loumaye E, Engrand P, Shoham Z, Hillier SG, Baird DT. Clinical evidence for an LH &quot;ceiling&quot;effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Hum Reprod 2003; 18: 314-322.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
